Warby Parker Inc.

WRBYSEC EDGAR

Ophthalmic Goods(DE)CIK: 1504776

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue from Contract with Customer, Excluding Assessed Tax	$669.8M	$598.1M	$540.8M	$393.7M	$370.5M
Cost of Goods and Services Sold	$304.5M	$257.1M	$223.0M	$161.8M	$147.4M
Gross Profit	$365.2M	$341.1M	$317.7M	$231.9M	$223.1M
Selling, General and Administrative Expense	$437.2M	$452.3M	$461.4M	$287.6M	$224.8M
Operating Income (Loss)	-$72.0M	-$111.2M	-$143.7M	-$55.6M	-$1.7M
Nonoperating Income (Expense)	$9.2M	$1.3M	-$347.0K	-$97.0K	$1.9M
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	-$62.8M	-$109.9M

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Assets	$676.5M	$580.3M	$568.7M	$440.6M	$444.8M
Assets, Current	$326.0M	$298.6M	$294.6M	$328.0M	$359.9M
Cash and Cash Equivalents, at Carrying Value	$254.2M	$216.9M	$208.6M	$256.4M	$314.1M
Accounts Receivable, after Allowance for Credit Loss, Current	$1.9M	$1.8M	$1.4M	$992.0K	$601.0K
Inventory, Net	$52.3M	$62.2M	$68.8M	$57.1M	$38.5M
Liabilities	$336.4M	$278.5M	$282.1M	$154.6M	$136.3M
Liabilities, Current	$130.4M	$127.1M	$129.6M	$118.1M

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Net Cash Provided by (Used in) Operating Activities	$61.0M	$10.4M	-$32.0M	$32.8M	$21.4M
Net Cash Provided by (Used in) Investing Activities	-$54.7M	-$60.2M	-$48.5M	-$20.1M	-$32.6M
Net Cash Provided by (Used in) Financing Activities	$2.9M	$3.3M	$23.0M	$245.9M	-$83.4M
Payments to Acquire Property, Plant, and Equipment	$53.7M	$60.2M	$48.5M	$20.1M	$32.6M
Payments for Repurchase of Common Stock	—	—	$8.1M	$0.00	$79.5M

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)